Background
Two congenital bleeding diatheses have been identified in Thoroughbred horses: Glanzmann thrombasthenia (GT) and a second, novel diathesis associated with abnormal platelet function in response to collagen and thrombin stimulation.
Journal of Veterinary Internal Medicine | |
Association of Factor V Secretion with Protein Kinase B Signaling in Platelets from Horses with Atypical Equine Thrombasthenia | |
J.W. Norris1  M. Pombo3  E. Shirley4  G. Blevins2  | |
[1] 5A60 Johns Hopkins Asthma and Allergy Center, Johns Hopkins Medical Institute – Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;19463 James Monroe HWY, Leesburg, VA;Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California, Davis, CA;Hunters Glen Veterinary Hospital, Inc., Veterinary Acupuncture Services of Tulsa LLC, Tulsa, OK | |
关键词: Factor V; AKT; Bleeding Diathesis; Horse; | |
DOI : 10.1111/jvim.13595 | |
来源: Wiley | |
Two congenital bleeding diatheses have been identified in Thoroughbred horses: Glanzmann thrombasthenia (GT) and a second, novel diathesis associated with abnormal platelet function in response to collagen and thrombin stimulation. Platelet dysfunction in horses with this second thrombasthenia results from a secretory defect. Two affected and 6 clinically normal horses. Ex vivo study. Washed platelets were examined for (1) expression of the αIIb-β3 integrin; (2) fibrinogen binding capacity in response to ADP and thrombin; (3) secretion of dense and α-granules; (4) activation of the mammalian target of rapamycin (mTOR)-protein kinase B (AKT) signaling pathway; and (5) cellular distribution of phosphatidylinositol-4-phosphate-3-kinase, class 2B (PIK3C2B) and SH2 containing inositol-5′-phosphatase 1 (SHIP1). Platelets from affected horses expressed normal amounts of αIIb-β3 integrin and bound fibrinogen normally in response to ADP, but bound 80% less fibrinogen in response to thrombin. α-granules only released 50% as much Factor V as control platelets, but dense granules released their contents normally. Protein kinase B (AKT) phosphorylation was reduced after thrombin activation, but mTOR Complex 2 (mTORC2) and phosphoinositide-dependent kinase 1 (PDK1) signaling were normal. SH2-containing inositol-5'-phosphatase 1 (SHIP1) did not localize to the cytoskeleton of affected platelets and was decreased overall consistent with reduced AKT phosphorylation. Defects in fibrinogen binding, granule secretion, and signal transduction are unique to this thrombasthenia, which we designate as atypical equine thrombasthenia.Abstract
Background
Hypothesis/Objectives
Animals
Methods
Results
Conclusions and clinical significance
CC BY-NC
Copyright © The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of American College of Veterinary Internal Medicine.
Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Files | Size | Format | View |
---|---|---|---|
RO202107150007600ZK.pdf | 3808KB | download |